Logo image of RSKD

RISKIFIED LTD-A (RSKD) Stock Fundamental Analysis

NYSE:RSKD - IL0011786493 - Common Stock

4.58 USD
+0.23 (+5.29%)
Last: 8/22/2025, 6:30:00 PM
4.5933 USD
+0.01 (+0.29%)
After Hours: 8/22/2025, 6:30:00 PM
Fundamental Rating

5

Overall RSKD gets a fundamental rating of 5 out of 10. We evaluated RSKD against 283 industry peers in the Software industry. While RSKD has a great health rating, there are worries on its profitability. RSKD has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

RSKD had positive earnings in the past year.
In the past year RSKD had a positive cash flow from operations.
RSKD had negative earnings in each of the past 5 years.
In multiple years RSKD reported negative operating cash flow during the last 5 years.
RSKD Yearly Net Income VS EBIT VS OCF VS FCFRSKD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

The Return On Assets of RSKD (-8.09%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of -10.35%, RSKD is in line with its industry, outperforming 50.88% of the companies in the same industry.
Industry RankSector Rank
ROA -8.09%
ROE -10.35%
ROIC N/A
ROA(3y)-11.33%
ROA(5y)-14.01%
ROE(3y)-14.06%
ROE(5y)-17.14%
ROIC(3y)N/A
ROIC(5y)N/A
RSKD Yearly ROA, ROE, ROICRSKD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -10 -20 -30

1.3 Margins

RSKD's Gross Margin of 50.80% is on the low side compared to the rest of the industry. RSKD is outperformed by 67.49% of its industry peers.
In the last couple of years the Gross Margin of RSKD has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for RSKD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.91%
GM growth 5Y0.76%
RSKD Yearly Profit, Operating, Gross MarginsRSKD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

9

2. Health

2.1 Basic Checks

RSKD does not have a ROIC to compare to the WACC, probably because it is not profitable.
RSKD has less shares outstanding than it did 1 year ago.
RSKD has more shares outstanding than it did 5 years ago.
There is no outstanding debt for RSKD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
RSKD Yearly Shares OutstandingRSKD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
RSKD Yearly Total Debt VS Total AssetsRSKD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 3.98 indicates that RSKD is not in any danger for bankruptcy at the moment.
RSKD has a Altman-Z score of 3.98. This is in the better half of the industry: RSKD outperforms 66.43% of its industry peers.
RSKD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.98
ROIC/WACCN/A
WACC9.08%
RSKD Yearly LT Debt VS Equity VS FCFRSKD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 6.96 indicates that RSKD has no problem at all paying its short term obligations.
RSKD has a Current ratio of 6.96. This is amongst the best in the industry. RSKD outperforms 92.23% of its industry peers.
A Quick Ratio of 6.96 indicates that RSKD has no problem at all paying its short term obligations.
RSKD's Quick ratio of 6.96 is amongst the best of the industry. RSKD outperforms 92.58% of its industry peers.
Industry RankSector Rank
Current Ratio 6.96
Quick Ratio 6.96
RSKD Yearly Current Assets VS Current LiabilitesRSKD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

6

3. Growth

3.1 Past

RSKD shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.69%.
The Revenue has grown by 10.05% in the past year. This is quite good.
The Revenue has been growing by 20.19% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)7.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
Revenue 1Y (TTM)10.05%
Revenue growth 3Y12.65%
Revenue growth 5Y20.19%
Sales Q2Q%2.96%

3.2 Future

RSKD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.76% yearly.
The Revenue is expected to grow by 8.86% on average over the next years. This is quite good.
EPS Next Y2.8%
EPS Next 2Y28.88%
EPS Next 3Y32.76%
EPS Next 5YN/A
Revenue Next Year5.18%
Revenue Next 2Y7.38%
Revenue Next 3Y8.86%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
RSKD Yearly Revenue VS EstimatesRSKD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
RSKD Yearly EPS VS EstimatesRSKD Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5 -2

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 32.71, the valuation of RSKD can be described as expensive.
64.66% of the companies in the same industry are more expensive than RSKD, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of RSKD to the average of the S&P500 Index (27.24), we can say RSKD is valued slightly more expensively.
Based on the Price/Forward Earnings ratio of 16.22, the valuation of RSKD can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of RSKD indicates a rather cheap valuation: RSKD is cheaper than 84.45% of the companies listed in the same industry.
RSKD's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 35.82.
Industry RankSector Rank
PE 32.71
Fwd PE 16.22
RSKD Price Earnings VS Forward Price EarningsRSKD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, RSKD is valued a bit cheaper than 78.80% of the companies in the same industry.
Industry RankSector Rank
P/FCF 22.38
EV/EBITDA N/A
RSKD Per share dataRSKD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates RSKD does not grow enough to justify the current Price/Earnings ratio.
RSKD's earnings are expected to grow with 32.76% in the coming years. This may justify a more expensive valuation.
PEG (NY)11.69
PEG (5Y)N/A
EPS Next 2Y28.88%
EPS Next 3Y32.76%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RSKD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RISKIFIED LTD-A

NYSE:RSKD (8/22/2025, 6:30:00 PM)

After market: 4.5933 +0.01 (+0.29%)

4.58

+0.23 (+5.29%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-18 2025-08-18/bmo
Earnings (Next)11-11 2025-11-11/bmo
Inst Owners60.74%
Inst Owner Change-3.55%
Ins Owners8.99%
Ins Owner ChangeN/A
Market Cap720.98M
Analysts74.67
Price Target5.91 (29.04%)
Short Float %1.41%
Short Ratio2.64
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)128.96%
Min EPS beat(2)-25.54%
Max EPS beat(2)283.46%
EPS beat(4)3
Avg EPS beat(4)89.35%
Min EPS beat(4)-25.54%
Max EPS beat(4)283.46%
EPS beat(8)7
Avg EPS beat(8)94.49%
EPS beat(12)11
Avg EPS beat(12)92.43%
EPS beat(16)15
Avg EPS beat(16)81.9%
Revenue beat(2)2
Avg Revenue beat(2)1.71%
Min Revenue beat(2)1.48%
Max Revenue beat(2)1.94%
Revenue beat(4)3
Avg Revenue beat(4)1.2%
Min Revenue beat(4)-1.66%
Max Revenue beat(4)3.03%
Revenue beat(8)3
Avg Revenue beat(8)0.17%
Revenue beat(12)6
Avg Revenue beat(12)0.62%
Revenue beat(16)9
Avg Revenue beat(16)0.78%
PT rev (1m)1.18%
PT rev (3m)3.63%
EPS NQ rev (1m)7.26%
EPS NQ rev (3m)-1.35%
EPS NY rev (1m)0%
EPS NY rev (3m)0.83%
Revenue NQ rev (1m)0.48%
Revenue NQ rev (3m)0.06%
Revenue NY rev (1m)0.26%
Revenue NY rev (3m)0.29%
Valuation
Industry RankSector Rank
PE 32.71
Fwd PE 16.22
P/S 2.16
P/FCF 22.38
P/OCF 21.93
P/B 2.01
P/tB 2.01
EV/EBITDA N/A
EPS(TTM)0.14
EY3.06%
EPS(NY)0.28
Fwd EY6.17%
FCF(TTM)0.2
FCFY4.47%
OCF(TTM)0.21
OCFY4.56%
SpS2.12
BVpS2.28
TBVpS2.28
PEG (NY)11.69
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.09%
ROE -10.35%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.8%
FCFM 9.66%
ROA(3y)-11.33%
ROA(5y)-14.01%
ROE(3y)-14.06%
ROE(5y)-17.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.91%
GM growth 5Y0.76%
F-Score6
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 14.59%
Cap/Sales 0.2%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.96
Quick Ratio 6.96
Altman-Z 3.98
F-Score6
WACC9.08%
ROIC/WACCN/A
Cap/Depr(3y)75.59%
Cap/Depr(5y)199.54%
Cap/Sales(3y)1.24%
Cap/Sales(5y)2.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
EPS Next Y2.8%
EPS Next 2Y28.88%
EPS Next 3Y32.76%
EPS Next 5YN/A
Revenue 1Y (TTM)10.05%
Revenue growth 3Y12.65%
Revenue growth 5Y20.19%
Sales Q2Q%2.96%
Revenue Next Year5.18%
Revenue Next 2Y7.38%
Revenue Next 3Y8.86%
Revenue Next 5YN/A
EBIT growth 1Y32.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year45.63%
EBIT Next 3Y59.8%
EBIT Next 5YN/A
FCF growth 1Y233%
FCF growth 3YN/A
FCF growth 5Y97.19%
OCF growth 1Y273.14%
OCF growth 3YN/A
OCF growth 5Y59.55%